CompletedN/Aketamine
Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
Sponsored by Nationwide Children's Hospital
NCT ID
NCT01645098
Target Enrollment
53 participants
Start Date
2011-08
Est. Completion
2013-06
About This Study
This is an interventional study on Duchenne muscular dystrophy patients who will be receiving sedation for a muscle biopsy as part of another study.
Conditions Studied
Interventions
- •Ketamine
- •Dexmedetomidine
Eligibility
Sex:MALE
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Patients undergoing a muscle biopsy for IRB11-00203.
Study Locations (1)
Nationwide Children's Hospital
Columbus, Ohio, United States